The current work shows the advancement of an additive manufactured multiplex immunosensor for the detection of dengue serotypes 1&2 in dengue patients on a single device with the LOD of 12.5 ng/ml. In this work, we created a QR-Code enabled additive manufactured case comprised of a paper-based electrode coated with ZnO NPs, which helps to enhance the detection signal and make it more selective, both serotype antibodies (DENV1-Ab & DENV2-Ab) were employed against DENV serotypes (DENV1-Ag & DENV2-Ag. QR-code technology was also integrated with the established platform to deliver sensor supporting information so that anybody may quickly obtain supporting sensing result details by scanning with a smartphone. The proposed highly advanced platform successfully detected DENV serotypes in dengue patients and showing a wide range of detection from 12.5 to 200 ng/ml with a LOD of 12.5 ng/ml.The results were also validated with conventional testing, i.e., Indirect Fluorescence Antibody Test (IFAT), so the developed multiplex-sensor became more applicable for the detection of DENV serotypes on a single tool having high sensitivity and selectivity, with a potential of commercialization.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bios.2024.116561 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protective.
Nat Commun
January 2025
Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
The standard dengue virus (DENV) neutralization assay inconsistently predicts dengue protection. We compare how IgG ELISA, envelope domain III (EDIII), or non-structural protein 1 (NS1) binding antibodies, and titers from plaque reduction neutralization tests (PRNTs) using standard and mature viruses are associated with dengue. The ELISA measures IgG antibodies that bind to inactivated DENV1-4.
View Article and Find Full Text PDFClinical characteristics of dengue virus infections in Karachi from 2019 to 2023: a cross-sectional study.
Sci Rep
December 2024
National Institute of Virology, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan.
Dengue fever is a vector-borne, acute, febrile, and self-limiting systemic viral infection that affects tropical and subtropical regions, including Pakistan. Karachi has a significant burden of Aedes aegypti and Aedes albopictus due to suitable breeding sites, weather, and rapid and unplanned urbanization of squatter areas. The country has limited surveillance studies on circulating serotypes of the dengue virus and the patient's clinical features evolving over temporal changes.
View Article and Find Full Text PDFTrends in dengue virus positivity & serotyping in Rajasthan.
Indian J Med Res
November 2024
Department of Health Research, Indian Council of Medical Research, New Delhi, India.
Background & objectives Dengue virus causes frequent outbreaks and epidemics with high morbidity and mortality. It is important to monitor the trends of the dengue virus and its serotypes. We carried out the present work to study the prevalence of the dengue virus and its serotypes in clinically suspected cases of dengue in Rajasthan.
View Article and Find Full Text PDFMultiplex sample-sparing assay for detecting type-specific antibodies to Zika and dengue viruses: an assay development and validation study.
Lancet Microbe
December 2024
Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA. Electronic address:
Background: Serology for dengue viruses (DENV) and Zika virus (ZIKV) has been hindered by antibody cross-reactivity, which limits the utility of these tests for surveillance and assessment of sero-status. Our aim was to develop a multiplexed IgG-based assay with increased accuracy to assess the history of previous DENV and ZIKV infections.
Methods: We developed and assessed the analytical performance of a sample-sparing, multiplexed, microsphere-based serological assay using domain III of the envelope protein (EDIII) of DENV serotypes 1-4 and ZIKV, the most variable region between each virus.
The importance of paying attention to the role of lipid-lowering drugs in controlling dengue virus infection.
Virol J
December 2024
Department of Clinical Pharmacy, Faculty of Pharmacy, Islamic Azad University of Medical Sciences, Tehran, Iran.
The Flaviviridae family includes the dengue virus (DENV). About half of the world's population is in danger because of the estimated 390 million infections and 96 million symptomatic cases that occur each year. An effective treatment for dengue fever (DF) does not yet exist.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!